The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPKD.L Regulatory News (BPKD)

  • There is currently no data for BPKD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Determination by UniCredit the selling price

13 Jul 2016 11:48

RNS Number : 0832E
Bank Pekao S.A.
13 July 2016
 

NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.

 

13.07.2016 - Report 16/2016: Information on the determination by UniCredit S.p.A. the selling price and number of shares in the sale of shares consisting approximately 10.0 % of the share capital of Bank Pekao S.A. in the way of accelerated book building

The Management Board of Bank Pekao S.A. (the "Bank") hereby informs that became aware on publication by UniCredit S.p.A. ("UniCredit") an announcement on the determination by UniCredit the selling price and number of shares sold in the sale of shares consisting approximately 10.0 % of the share capital of the Bank in the way of accelerated bookbuilding with the following information:

"Further to the press release published today, UniCredit S.p.A. ("UniCredit") announces that it has sold 26.2 million existing ordinary shares in Bank Pekao S.A. ("Pekao" or the "Company") to institutional investors, corresponding to approximately 10.0% of the Company's issued share capital, at a price of 126 PLN per ordinary share in an accelerated placement (the "Placement").

Gross proceeds raised by UniCredit from the Placement amounted to approximately PLN 3.3 billion (equal to c. € 749 million*). The price represents a discount of approximately 6% to the last pre-announcement closing price of Pekao and is estimated to translate to an increase of approximately 12 basis points in the UniCredit Group CET1 ratio.

After the completion of the Placement, UniCredit continues to hold a controlling shareholding in Pekao, corresponding to 40.1% of the Company's share capital. In the context of the Placement, UniCredit has agreed to a 90 days lock-up period with respect to its remaining controlling shareholding in Pekao, subject to customary carve-outs.

This transaction, following closely after the successful placing of 10% of FinecoBank's ordinary share capital concluded this morning, is another firm indication that UniCredit will act decisively and swiftly to seize value creative opportunities in line with its renewed focus on strictly disciplined capital management and pro-active capital optimisation actions. In the meantime, UniCredit confirms its key focus on delivering its unique Western, Eastern and Central European network to its extensive client base.

Morgan Stanley & Co. International plc, Citigroup, UBS Limited and UniCredit Corporate & Investment Banking acted as Joint Bookrunners for the Placement.

* Assuming EUR/PLN exchange rate equal to 4.4171 (ECB foreign exchange reference rate as of 12 July 2016)."

Legal basis:

Article 17 sec. 1 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC

 

Legal disclaimer

The communication constitutes fulfillment of disclosure obligations to which the Bank is subject a public company with shares listed on a regulated market in Poland and is not an offer for sale of securities in the United States or any other jurisdiction. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). UniCredit does not intend to register any portion of the Placement in the United States, and does not intend to conduct a public offering of securities in the United States.

This communication in the United States is intended only for QIBs and by accepting delivery of this communication in the United States you confirm that you are a QIB. The securities referred to herein may only be sold pursuant to Regulation S of the Securities Act and in the US, pursuant to an exemption from the Securities Act, strictly only to a limited number of QIBs (as defined in Rule 144A under the Securities Act) and in certain other countries only to authorised professional institutional investors. The securities are "restricted securities" as defined in Rule 144A under the Securities Act and any allocation will only be made on the basis the purchaser executes an investor representation letter.

Distribution in Canada to Accredited Investors in Ontario and Quebec, might only be available to accounts which are also permitted clients.

The material set forth herein is for information purposes only and is not an offer to sell, or the solicitation of an offer to buy, any securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful and, in particular, is not for release, publication or distribution in or into the United States, Australia, Canada or Japan.

The publication of this information does not constitute the making available of information to

promote the purchase or acquisition of securities or an inducement of their purchase or acquisition within the meaning of Article 53 section 1 of Polish Act of 29 July 2005 on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies, as amended (the "Act on Public Offering"), and does not constitute a promotional campaign within the meaning of Article 53 of the Act on Public Offering.

This communication and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this communication or any subsequent offer should inform themselves about and observe any such restriction and must not under any circumstances forward this communication to any other person. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

This communication is only addressed to and directed at persons in Member States of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive. In addition, in the United Kingdom, this communication is being distributed to, and is directed only at, qualified investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Financial Promotion Order"), (ii) persons falling within any of the categories of persons described in Article 49 of the Financial Promotion Order and (iii) any other persons to whom it may otherwise lawfully be made (all such persons together being referred to as "relevant persons").

Any investment or investment activity to which these materials relate are available only to relevant persons in the United Kingdom and qualified investors in any member state of the European Economic Area other than the United Kingdom, and will only be engaged with such persons.

Any investment decision to buy shares must be made solely on the basis of publicly available information. Such information is not the responsibility of Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG and has not been independently verified by Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG or UniCredit.

Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG are acting for UniCredit and no one else in connection with the offering and will not be responsible to anyone other than UniCredit for providing advice or protections afforded to clients in relation to any transaction or any matters referred to this communication.

Each of Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG may participate in the offering on a proprietary basis.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADMGMNGFVGVZM
Date   Source Headline
5th Nov 20187:00 amRNSBank Pekao S.A. -2018 EU-Wide Stress Test Results
30th Oct 20185:47 pmRNSDismissal of the claim
30th Oct 201811:26 amRNSSeries C bonds as instruments in Tier II capital
30th Oct 201811:19 amRNSCorrection of the Report no. 24/2018
17th Oct 20182:27 pmRNSFitch Ratings update of Pekao ratings and outlook
16th Oct 20187:00 amRNSS&P Global Ratings
4th Oct 20186:26 pmRNSMB resolutions on issuance of subordinated bonds
25th Sep 20185:58 pmRNSDismissal of the shareholder's claim
11th Sep 20184:54 pmRNSNon-public Issue of Subordinated Bonds
8th Aug 20187:00 amRNSDisclosure of delayed inside information
8th Aug 20187:00 amRNSTermination of the negotiations with Alior Bank
1st Aug 20187:00 amRNSStatement of Financial Supervision Authority
31st Jul 20187:00 amRNSNotification of acquisition Bank's phantom shares
29th Jun 20187:00 amRNSOpinion of the PFSC regarding the O-SII buffer
27th Jun 20186:29 pmRNSShareholders holding at least 5% of votes at OGM
22nd Jun 20185:17 pmRNSS&P: confirmation of long-term, short-term ratings
22nd Jun 201812:20 pmRNSResult of OGM
21st Jun 20181:06 pmRNSResolution of the OGM on distribution of profit
21st Jun 20181:02 pmRNSLetter of Polish Financial Supervision Authority
15th Jun 20187:00 amRNSDraft resolutions for the Ordinary General Meeting
11th Jun 20187:00 amRNSNotification by Nationale-Nederlanden PTE SA
1st Jun 20185:27 pmRNSAmendment of the agenda of the AGM
29th May 20187:00 amRNSANNOUNCEMENT ON CONVENING THE AGM
24th May 20186:29 pmRNSDismissal the shareholder's appeal
10th May 20182:38 pmRNS1st Quarter Results
10th May 201810:58 amRNS1st Quarter Results
3rd Apr 201810:56 amRNSProposed dividend from 2017 net profit
20th Mar 20184:36 pmRNSInformation of KNF regarding dividend for 2017.
27th Feb 201810:22 amRNSUnconsolidated Financial Statements for 2017
27th Feb 201810:14 amRNSConsolidated Financial Statements for 2017
27th Feb 20189:57 amRNSChange publication date for first quarter of 2018
10th Jan 20181:21 pmRNSDecision of Polish Financial Supervision Authority
21st Dec 20175:14 pmRNSDecision of Polish Financial Supervision Authority
21st Dec 20175:14 pmRNSDates of financial statements release in 2018
21st Dec 20175:08 pmRNSKNF reg min. levels of capital ratios in 2018...
21st Dec 20175:03 pmRNSClosing transaction of acquisition 51% stakePPIM
8th Dec 20177:00 amRNSDecision of the Financial Stability Committee
5th Dec 20177:56 amRNSRejection the shareholder's appeal
5th Dec 20177:55 amRNSStanding of the PFSA reg. O-SII buffer
22nd Nov 20175:12 pmRNSInformation on the website of the PFSA reg Pekao
22nd Nov 20175:11 pmRNSThe discontinuance of the cassation proceedings
8th Nov 201711:08 amRNSStrategy/Company/Ops Update - Replacement
8th Nov 201710:59 amRNS3rd Quarter Results
8th Nov 201710:44 amRNSStrategy/Company/Ops Update
7th Nov 20175:12 pmRNSPFSA approval - M.Krupinski as President of Bank
24th Oct 20177:00 amRNSFitch Ratings affirmed Long-Term IDRs at (A-) ...
24th Oct 20177:00 amRNSSigning of letter of intent with Alior Bank S.A.
24th Oct 20177:00 amRNSDisclosure of the delayed inside information
24th Oct 20177:00 amRNSIssuance of subordinated bonds of Bank Pekao S.A.
17th Oct 20174:49 pmRNSApproval of PFSA to entrust Mr. M. Lusztyn ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.